Pharming Group NV (PHARM) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
Pharming Group NV (PHARM) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow (€32.03 Million) in capital expenditures (€70.00K). See PHARM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
€32.03 Million
EUR
Capital Expenditures
€70.00K
EUR
Data as of
Sep 2025
Most recent filing
Pharming Group NV Capital Reinvestment Ratio (2017–2022)
This chart tracks Pharming Group NV's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Pharming Group NV (2017–2022)
Year-by-year Capital Reinvestment Ratio for Pharming Group NV from 2017 to 2022. For live market cap and broader valuation context, see Pharming Group NV stock valuation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.09x | €22.90 Million | €1.98 Million | ▼ -80.5% |
| 2021 | 0.44x | €36.13 Million | €15.96 Million | ▲ +144.0% |
| 2020 | 0.18x | €90.98 Million | €16.47 Million | ▼ -47.0% |
| 2019 | 0.34x | €74.56 Million | €25.44 Million | ▲ +265.6% |
| 2018 | 0.09x | €46.19 Million | €4.31 Million | ▼ -41.0% |
| 2017 | 0.16x | €45.84 Million | €7.25 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow